title: Development of lymphomas containing Epstein-Barr virus after therapy with hyper-CVAD regimen.
authors.affiliation: Abramson Cancer Center, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA. Electronic address: marlise.luskin@uphs.upenn.edu.
authors.forename: Marlise R
authors.initials: MR
authors.lastname: Luskin
authors.affiliation: Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
authors.forename: Darshan B
authors.initials: DB
authors.lastname: Roy
authors.affiliation: Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
authors.forename: Mariusz A
authors.initials: MA
authors.lastname: Wasik
authors.affiliation: Abramson Cancer Center, Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
authors.forename: Alison W
authors.initials: AW
authors.lastname: Loren
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002051:Burkitt Lymphoma / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D020031:Epstein-Barr Virus Infections / Q000139:chemically induced / Q000175:diagnosis* / Q000821:virology; D005260:Female; D004854:Herpesvirus 4, Human / Q000502:physiology; D006689:Hodgkin Disease / Q000139:chemically induced / Q000175:diagnosis* / Q000821:virology; D054884:Host-Pathogen Interactions; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000139:chemically induced / Q000175:diagnosis* / Q000821:virology; D008297:Male; D008875:Middle Aged; D054218:Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide
keywords: Epstein-Barr virus; Hyper-CVAD; Immunodeficiency; Lymphoma